Skip to main content
Fig. 8 | Journal of Nanobiotechnology

Fig. 8

From: Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect

Fig. 8

A The hemolysis of PC (positive control), NC (negative control), SHP1i (I), Lips-SHP1i (II), MM@Lips (III) and MM@Lips-SHP1i (IV) to mouse red blood cells (DI water as a positive control and saline as a negative control); B Mouse blood panel and serum biochemistry analysis before (0d, control) and after injection of MM@Lips-SHP1i for 1, 7, 21d; C H&E staining of collected organs including the heart, liver, spleen, lungs, kidneys of healthy mice after injected with MM@Lips-SHP1i at 1, 7 and 21 d and control mice (scale bar: 200 μm)

Back to article page